Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Income from Continuing Operations (2016 - 2026)

Phibro Animal Health has reported Income from Continuing Operations over the past 14 years, most recently at 27459000.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 762.14% year-over-year to 27459000.0; the TTM value through Dec 2025 reached 92090000.0, up 1157.72%, while the annual FY2025 figure was 48264000.0, 603.85% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 27459000.0 at Phibro Animal Health, up from 26527000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 27459000.0 in Q4 2025 and troughed at 11243000.0 in Q2 2024.
  • A 5-year average of 8628750.0 and a median of 7092500.0 in 2022 define the central range for Income from Continuing Operations.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 307.86% in 2023 and later soared 762.14% in 2025.
  • Year by year, Income from Continuing Operations stood at 17465000.0 in 2021, then tumbled by 58.72% to 7210000.0 in 2022, then crashed by 82.33% to 1274000.0 in 2023, then soared by 150.0% to 3185000.0 in 2024, then surged by 762.14% to 27459000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for PAHC at 27459000.0 in Q4 2025, 26527000.0 in Q3 2025, and 17224000.0 in Q2 2025.